AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients

about

Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients.

P2860

Q47097853-CF0CA1C1-DCCE-41A1-AB31-7E93D870A347

P2860

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients

Item

http://www.wikidata.org/entity/Q37427945

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients

@en

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients.

@nl

type

Item

label

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients

@en

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients.

@nl

prefLabel

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients

@en

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients.

@nl

P1476

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients

@en

P2093

Bingyin Shi

http://www.w3.org/2001/XMLSchema#string

Changwei Wang

http://www.w3.org/2001/XMLSchema#string

Ke Gao

http://www.w3.org/2001/XMLSchema#string

Lihong Chen

http://www.w3.org/2001/XMLSchema#string

Peng Hou

http://www.w3.org/2001/XMLSchema#string

Rui Liu

http://www.w3.org/2001/XMLSchema#string

Xinyuan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics

An integrated genomic analysis of human glioblastoma multiforme

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The 2007 WHO classification of tumours of the central nervous system

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Combinatorial control of gene expression by nuclear receptors and coregulators

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer.

Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC).

P304

2052-2060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.16069

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27877220

http://www.w3.org/2001/XMLSchema#string

P932

5118668

http://www.w3.org/2001/XMLSchema#string

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients

about

P2860

P2860

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932